Drugmaker CEO to testify on “outrageously” priced weight-loss drugs - Ars Technica
- Drugmaker CEO to testify on “outrageously” priced weight-loss drugs Ars Technica
- Novo Nordisk CEO to face off with Bernie Sanders over 1300% Ozempic markup in U.S. Fortune
- Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy Reuters
- Bernie Sanders will grill Novo Nordisk's CEO over Ozempic prices Quartz
- Sanders drops subpoena effort after Novo Nordisk CEO agrees to testify The Hill